Extra-abdominal cytoreductive techniques in ovarian cancer: how far can (should) we go?

Int J Gynecol Cancer. 2024 Mar 4;34(3):379-385. doi: 10.1136/ijgc-2023-004630.

Abstract

Complex surgery is an essential component in the management of advanced ovarian cancer. Furthermore, achieving complete gross resection in cytoreductive surgery appears to be associated with significant survival benefits in patients with advanced ovarian cancer. The goal of this review is to demonstrate the advancement of surgical techniques in gynecologic oncology surgery, including resection of disease within the intrathoracic and inguinal regions. This progress has expanded the option of surgery to more patients, especially those who would have previously been deemed inoperable. In this review we describe the most notable studies and reports of surgical resection of ovarian cancer involving cardiophrenic/supradiaphragmatic lymph nodes, mediastinum, lung pleura or parenchyma, and the inguinal region. We also describe the growing role that video-assisted thoracic surgery has played in advanced ovarian cancer diagnosis and management. The studies, series, and reports described demonstrate that comprehensive surgical procedures outside of the abdomen or pelvis can be both safe and feasible in properly selected patients. They also suggest that resection of disease outside of the abdomen or pelvis may benefit appropriately selected patients. Future studies are necessary to identify which patients may benefit most from upfront surgery versus neoadjuvant chemotherapy when ovarian cancer metastasis is present in the thoracic or inguinal regions.

Keywords: Cytoreduction surgical procedures; Gynecologic Surgical Procedures; Ovarian Cancer; Surgical Oncology.

Publication types

  • Review

MeSH terms

  • Abdomen
  • Carcinoma, Ovarian Epithelial
  • Cytoreduction Surgical Procedures*
  • Female
  • Humans
  • Ovarian Neoplasms* / surgery
  • Pelvis